Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 13, 2022 01:00 ET | Source: LEXIBOOK

Lexibook® étoffe sa gamme de jeux d’arcade et lance le Flipper Electronique Gardiens de la Galaxie !

Les Ulis, le 13 décembre 2022 Lexibook® étoffe sa gamme de jeux d’arcade et lance le Flipper Electronique Gardiens de la Galaxie ! Un flipper de table pour s’entrainer seul ou entre amis ! ...
December 13, 2022 00:07 ET | Source: LeddarTech inc.

LeddarTech présentera au CES 2023 ses nouveaux produits de fusion de données de capteurs et de perception et son logiciel LeddarVision, primé à l’événement, du 5 au 8 janvier à Las Vegas

QUÉBEC, 13 déc. 2022 (GLOBE NEWSWIRE) -- LeddarTech®, chef de file de calibre mondial dans les technologies logicielles pour systèmes avancés d’aide à la conduite (systèmes ADAS) et de...
December 13, 2022 00:07 ET | Source: LeddarTech inc.

LeddarTech Showcasing New Sensor Fusion and Perception Products and CES Award-Winning LeddarVision Software January 5-8 in Las Vegas at CES 2023

QUEBEC, Dec. 13, 2022 (GLOBE NEWSWIRE) -- LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD software technology, is pleased to announce its participation...
December 13, 2022 00:01 ET | Source: Insurance Institute for Highway Safety

New crash test spotlights lagging protection for rear passengers

ARLINGTON, Va., Dec. 13, 2022 (GLOBE NEWSWIRE) -- The Insurance Institute for Highway Safety is updating its longest-running crash test, the moderate overlap front evaluation, to address a growing...
December 12, 2022 20:34 ET | Source: CARINA BIOTECH PTY LTD

Carina Biotech Submits an Investigational New Drug (IND) Application to US FDA for LGR5-Targeted CAR-T Cell Therapy Candidate

HIGHLIGHTS Files its first IND application for a CAR-T cell therapy targeting a solid cancer. The IND application is directed at a first-in-human Phase 1/2a clinical trial in advanced colorectal...
December 12, 2022 18:50 ET | Source: Tessa Therapeutics Ltd

Tessa Therapeutics Announces Updated Safety, Efficacy and Biomarker Data from Phase 2 Trial of Autologous CD30.CAR-T Therapy (TT11) in Relapsed or Refractory Classical Hodgkin Lymphoma

Updated Results from CHARIOT Phase 2 trial presented at the 2022 ASH Annual Meeting indicate a 73.3% overall response rate and 60% complete response rate from 15 heavily pre-treated patients dosed...
December 12, 2022 16:30 ET | Source: Magenta Therapeutics

Magenta Therapeutics Presents Positive MGTA-117 Clinical Data at the American Society of Hematology (ASH) Annual Meeting and Provides Program Updates

– MGTA-117 preliminary clinical results from 15 patients across three dose-escalation cohorts of the ongoing Phase 1/2 clinical trial shows single-agent activity with no dose-limiting toxicities;...
December 12, 2022 16:15 ET | Source: Greystone Housing Impact Investors LP

Greystone Housing Impact Investors LP Rings Opening Bell at New York Stock Exchange to Commemorate New Name and Listing

NEW YORK, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Greystone Housing Impact Investors LP (the “Partnership”) (NYSE: GHI), which recently changed its name from America First Multifamily Investors, L.P.,...
December 12, 2022 16:05 ET | Source: CNB Financial

CNB Bank Introduces Women-Focused, Impressia Bank

CLEARFIELD, Pa., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Together, Michael Peduzzi, President and CEO of CNB Bank, and Angela Wilcoxson, EVP/Chief Commercial Banking Officer, have announced plans to...
December 12, 2022 16:05 ET | Source: Vincerx Pharma, Inc.

Vincerx Pharma Provides American Society of Hematology Annual Meeting 2022 Poster Highlights on Enitociclib in Multiple Tumor Types

In a multiple myeloma (MM) preclinical study, antitumor efficacy was observed with enitociclib as a monotherapy and in combination with several anti-MM agents Significant MYC downregulation was...